Bulletin
Investor Alert

New York Markets Open in:

Seagen Inc.

NAS: SGEN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203326163/composite

$

214.00

Change

+0.79 +0.37%

Volume

Volume 91,318

Nov 30, 2023, 7:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203326163/composite

Previous close

$ 213.52

$ 213.21

Change

-0.31 -0.15%

Day low

Day high

$212.82

$213.95

Open
Open: 213.60

52 week low

52 week high

$116.08

$217.51

Open

Market cap

$40.28B

Average volume

1.40M

P/E ratio

N/A

Rev. per Employee

$706,496

EPS

-4.01

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sgen

MarketWatch News on SGEN

  1. Incyte Corp. stock rises Thursday, outperforms market

    5:18 p.m. Nov. 30, 2023

    - MarketWatch Automation

  2. ImmunoGen Stock Soars 81% on AbbVie's $10.1 Billion Takeover

    10:40 a.m. Nov. 30, 2023

    - Barron's Online

  3. Incyte Corp. stock rises Wednesday, outperforms market

    5:18 p.m. Nov. 29, 2023

    - MarketWatch Automation

  4. Incyte Corp. stock falls Tuesday, underperforms market

    5:18 p.m. Nov. 28, 2023

    - MarketWatch Automation

  5. Incyte Corp. stock falls Monday, underperforms market

    5:17 p.m. Nov. 27, 2023

    - MarketWatch Automation

  6. Incyte Corp. stock rises Wednesday, still underperforms market

    5:18 p.m. Nov. 22, 2023

    - MarketWatch Automation

  7. Incyte Corp. stock underperforms Tuesday when compared to competitors

    5:18 p.m. Nov. 21, 2023

    - MarketWatch Automation

  8. Incyte Corp. stock outperforms competitors on strong trading day

    5:18 p.m. Nov. 20, 2023

    - MarketWatch Automation

  9. Incyte Corp. stock outperforms competitors on strong trading day

    5:17 p.m. Nov. 17, 2023

    - MarketWatch Automation

  10. Incyte Corp. stock falls Thursday, underperforms market

    5:17 p.m. Nov. 16, 2023

    - MarketWatch Automation

  11. Incyte Corp. stock rises Wednesday, outperforms market

    5:17 p.m. Nov. 15, 2023

    - MarketWatch Automation

  12. Incyte Corp. stock outperforms competitors on strong trading day

    5:17 p.m. Nov. 14, 2023

    - MarketWatch Automation

  13. Incyte Corp. stock outperforms market on strong trading day

    5:18 p.m. Nov. 13, 2023

    - MarketWatch Automation

  14. Incyte Corp. stock underperforms Friday when compared to competitors

    5:17 p.m. Nov. 10, 2023

    - MarketWatch Automation

  15. Incyte Corp. stock underperforms Thursday when compared to competitors

    5:17 p.m. Nov. 9, 2023

    - MarketWatch Automation

  16. Incyte Corp. stock falls Wednesday, underperforms market

    5:17 p.m. Nov. 8, 2023

    - MarketWatch Automation

  17. Pfizer's Weight Loss Pill Is a Do-Or-Die Milestone

    1:33 p.m. Nov. 8, 2023

    - Barron's Online

  18. Incyte Corp. stock rises Tuesday, still underperforms market

    5:17 p.m. Nov. 7, 2023

    - MarketWatch Automation

  19. Incyte Corp. stock falls Monday, underperforms market

    5:18 p.m. Nov. 6, 2023

    - MarketWatch Automation

  20. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sgen

Other News on SGEN

  1. AbbVie to Buy ImmunoGen for More Than $10 Billion

    2:34 a.m. Today

    - The Wall Street Journal Interactive Edition

  2. How Biden’s Inflation Reduction Act Killed a Cancer Study

    6:04 p.m. Nov. 2, 2023

    - The Wall Street Journal Interactive Edition

  3. ‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon

    1:32 a.m. Oct. 27, 2023

    - The Wall Street Journal Interactive Edition

  4. Pfizer Looks for a Covid Bottom

    1:33 a.m. Oct. 18, 2023

    - The Wall Street Journal Interactive Edition

  5. The Hedge Fund That Made a Killing Betting Against Lina Khan

    5:05 a.m. Sept. 25, 2023

    - The Wall Street Journal Interactive Edition

  6. S&P 500 Drops for Third Straight Week

    1:33 a.m. Sept. 23, 2023

    - The Wall Street Journal Interactive Edition

  7. Biden FTC’s Antitrust Bark Proves Worse Than Its Bite

    1:33 a.m. Sept. 7, 2023

    - The Wall Street Journal Interactive Edition

  8. Pfizer’s Covid Boost Crashes to Earth

    1:34 a.m. Aug. 7, 2023

    - The Wall Street Journal Interactive Edition

  9. Deal Activity Slumps as Pricing Proves to Be a Sticking Point

    1:33 a.m. July 12, 2023

    - The Wall Street Journal Interactive Edition

  10. FTC’s Amgen Activism Will Spare Smaller Biotechs

    2:33 p.m. June 2, 2023

    - The Wall Street Journal Interactive Edition

  11. Pfizer’s Earnings Fall With Cooling Demand for Covid-19 Products

    1:32 a.m. May 3, 2023

    - The Wall Street Journal Interactive Edition

  12. Starbucks, Ford, Apple Lead Another Busy Earnings Week

    1:02 p.m. May 25, 2023

    - The Wall Street Journal Interactive Edition

  13. 10-Q: SEAGEN INC.

    7:37 a.m. April 27, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  14. Bristol-Myers CEO Giovanni Caforio to Step Down

    1:33 a.m. April 27, 2023

    - The Wall Street Journal Interactive Edition

  15. How to Tell Biotech’s Likely Winners From Losers

    2:03 p.m. May 30, 2023

    - The Wall Street Journal Interactive Edition

  16. Merck to Buy Prometheus Biosciences

    7:02 a.m. April 17, 2023

    - The Wall Street Journal Interactive Edition

  17. First Republic Bank, T-Mobile, Credit Suisse: Stocks That Defined the Week

    1:32 a.m. March 18, 2023

    - The Wall Street Journal Interactive Edition

  18. Corrections & Amplifications

    1:32 a.m. March 14, 2023

    - The Wall Street Journal Interactive Edition

  19. Pfizer Agrees to Buy Seagen for $43 Billion

    2:01 p.m. June 2, 2023

    - The Wall Street Journal Interactive Edition

  20. Pfizer Overpays for Seagen, but Who’s Counting

    2:15 p.m. June 2, 2023

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...
/news/pressrelease/company/us/sgen

Press Releases on SGEN

  1. Seagen Reports First Quarter 2023 Financial Results

    7:00 a.m. April 27, 2023

    - BusinessWire - BZX

  2. MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting

    3:15 p.m. April 18, 2023

    - BusinessWire - BZX

  3. SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates SGEN, UNVR, CVT

    1:18 p.m. April 17, 2023

    - PR Newswire - PRF

Rates »

Link to MarketWatch's Slice.